The expression of inflammatory cytokines in lung tissue plays an important role in immune function of the lung. In this study, we tested whether aerosol delivery of the gene of interferon-γ (IFNγ) could affect inflammatory cytokine expression in mouse lung.
Methods:
Murine IFNγ-expressing plasmids (pcDNA-IFNγ) complexed with polyethylenimine (PEI) (PEI/pcDNA-IFNγ) were constructed, and their transfection efficiency was assessed in vivo using real-time quantitative RT-PCR and enzyme-linked immunosorbent assay. After aerosol administration of the plasmid complexes and confirmation of the IFNγ plasmid location in lung tissue, we measured mRNA levels of the inflammatory cytokines interleukin-1 (IL-1), IL-6, IL-10, tumor necrosis factor-α (TNF-α), and granulocyte-macrophage colony-stimulating factor (GM-CSF) on days 1 to 7 in mouse lung tissues using real-time RT-PCR.
Results:
IFNγ mRNA expression in mouse lung was significantly increased 24 hr after a single aerosol administration of PEI/pcDNA-IFNγ and gradually decreased over the next 5 days, whereas the mRNA expressions of IL-1, IL-6, and GM-CSF were markedly decreased, but not those of IL-10 and TNF-α.
Conclusions:
PEI/IFNγ gene therapy delivered by aerosol has immune-regulating potential by suppressing lung cytokine mRNA expression, and therefore may alleviate lung disease.
Get full access to this article
View all access options for this article.
References
1.
RijavecM, VolarevicS, OsolnikK, KosnikM, and KorosecP: Natural killer T cells in pulmonary disorders. Respir Med., 2011; 105Suppl 1:S20–S25.
2.
ToscaMA, SilvestriM, MorandiF, PrigioneI, PistorioA, CiprandiG, and RossiGA: Impairment of lung function might be related to IL-10 and IFNγ defective production in allergic children. Immunol Lett., 2011; 140:104–106.
3.
OpitzB, van LaakV, EitelJ, and SuttorpN: Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med., 2010; 181:1294–1309.
4.
BarnesPJ: Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol., 2008; 8:183–192.
5.
CorkeryK: Inhalable drugs for systemic therapy. Respir Care., 2000; 45:831–835.
6.
LaubeBL: The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir Care., 2005; 50:1161–1176.
7.
PrzybyszewskaM, MiłoszewskaJ, RzońcaS, TrembaczH, PyśniakK, KotlarzA, SwobodaP, ZalewskaM, and MałeckiM: Soluble TNF-α receptor I encoded on plasmid vector and its application in experimental gene therapy of radiation-induced lung fibrosis. Arch Immunol Ther Exp., 2011; 59:315–326.
8.
XuY, HouJ, LiuZ, YuH, SunW, XiongJ, LiaoZ, ZhouF, XieC, and ZhouY: Gene therapy with tumor-specific promoter mediated suicide gene plus IL-12 gene enhanced tumor inhibition and prolonged host survival in a murine model of Lewis lung carcinoma. J Transl Med., 2011; 9:39.
9.
SzokolJW, MurphyGS, VenderJS, and NitsunM: Gene therapy in heart and lung disease. Curr Opin Anaesthesiol., 2004; 17:13–20.
10.
HuX, and LiJ: Construction and identification of mouse gamma interferon gene eukarotic expressing plasmid. J Morn Clin Med Bioeng., 2003; 6:482–483.
11.
JiaSF, WorthLL, DensmoreCL, XuB, DuanX, and KleinermanES: Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res., 2003; 9:3462–3468.
12.
JuhásS, CikosS, CzikkováS, VeseláJ, Il'kováG, HájekT, DomarackáK, DomarackýM, BujnákováD, RehákP, and KoppelJ: Effects of borneol and thymoquinone on TNBS-induced colitis in mice. Folia Biol (Praha)., 2008; 54:1–7.
13.
DensmoreCL: The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy. Curr Cancer Drug Targets., 2003; 3:275–286.
14.
BoussifO, Lezoualc'hF, ZantaMA, MergnyMD, SchermanD, DemeneixB, and BehrJP: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA., 1995; 92:7297–7301.
15.
YangH, SunW, and MaZ: Effect of jet nebulizer on plasmid DNA integrity and the research of protective methods. Chin Biotech., 2011; 30:44–48.
16.
GautamA, DensmoreCL, XuB, and WaldrepJC: Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery. Mol Ther., 2000; 2:63–70.
17.
OhYK, SuhD, KimJM, ChoiHG, ShinK, and KoJJ: Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther., 2002; 9:1627–1632.
18.
De BoerML, HuJ, KalvakolanuDV, HasdayJD, and CrossAS: IFN-γ inhibits lipopolysaccharide-induced interleukin-1β in primary murine macrophages via a Stat1-dependent pathway. J Interferon Cytokine Res., 2001; 21:485–494.
19.
KeslacyS, TlibaO, BaidouriH, and AmraniY: Inhibition of tumor necrosis factor-α-inducible inflammatory genes by interferon-γ is associated with altered nuclear factor-κB transactivation and enhanced histone deacetylase activity. Mol Pharmacol., 2007; 71:609–618.
20.
NakagomeK, OkunishiK, ImamuraM, HaradaH, MatsumotoT, TanakaR, MiyazakiJ, YamamotoK, and DohiM: IFN-γ attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. J Immunol., 2009; 183:209–220.
21.
OzawaH, AibaS, Nakagawa, and TagamiH: Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol., 1996; 26:648–652.
22.
StrainAJ: The uptake and fate of exogenous cellular DNA in mammalian cells. Dev Biol (Basel)., 2006; 123:23–28.
23.
MastersSL, MielkeLA, CornishAL, SuttonCE, O'DonnellJ, CengiaLH, RobertsAW, WicksIP, MillsKH, and CrokerBA: Regulation of interleukin-1β by interferon-γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep., 2010; 11:640–646.
24.
GautamA, DensmoreCL, and WaldrepJC: Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther., 2001; 8:254–257.
25.
PerroneLA, SzretterKJ, KatzJM, MizgerdJP, and TumpeyTM: Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis., 2010; 202:1161–1170.
26.
BaylissTJ, SmithJT, SchusterM, DragnevKH, and RigasJR: A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther., 2011; 11:1663–1668.
27.
PazdrakK, YoungTW, StraubC, StaffordS, and KuroskyA: Priming of eosinophils by GM-CSF is mediated by protein kinase CβII-phosphorylated L-plastin. J Immunol., 2011; 186:6485–6496.
28.
LauS, DiazK, SmaldoneG, and CondosR: The effect of inhaled IFNγ on the cytokine profile in the alveolar space in idiopathic pulmonary fibrosis (IPF). Chest., 2011; 140(4_MeetingAbstracts): 928A.
29.
DiazKT, SkariaS, HarrisK, SolomitaM, LauS, BauerK, SmaldoneGC, and CondosR: Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv., 2012; 25:79–87.
30.
WalshGM: Novel cytokine-directed therapies for asthma. Discov Med., 2011; 11:283–291.
